TVGN (STOCKS)
Tevogen Bio Holdings Inc. Common Stock
$0.279500
+0.019500 (+7.50%)
Prev close: $0.260000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Ryan Saadi
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $58.08M
- Employees
- 17
- P/E (TTM)
- -1.46
- P/B (TTM)
- -3.09
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $43.30K |
| Operating Expenses | $30.89M |
| Research and Development | $11.84M |
| Other Operating Expenses | $19.05M |
| Operating Income/Loss | -$30.89M |
| Income/Loss From Continuing Operations After Tax | -$31.04M |
| Income/Loss From Continuing Operations Before Tax | -$13.68M |
| Net Income/Loss | -$31.04M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$31.04M |
| Net Income/Loss Available To Common Stockholders, Basic | -$31.42M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $374.49K |
| Preferred Stock Dividends And Other Adjustments | $374.49K |
| Basic Earnings Per Share | -$0.18 |
| Diluted Earnings Per Share | -$0.18 |
| Basic Average Shares | 173,758,586 |
| Diluted Average Shares | 173,758,586 |
| Assets | $4.49M |
| Current Assets | $2.12M |
| Noncurrent Assets | $2.37M |
| Fixed Assets | $163.93K |
| Other Non-current Assets | $2.21M |
| Liabilities | $12.32M |
| Current Liabilities | $6.74M |
| Accounts Payable | $3.31M |
| Other Current Liabilities | $3.43M |
| Noncurrent Liabilities | $5.58M |
| Equity | -$7.82M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | -$7.82M |
| Liabilities And Equity | $4.49M |
| Net Cash Flow From Operating Activities | -$13.19M |
| Net Cash Flow From Operating Activities, Continuing | -$13.19M |
| Net Cash Flow From Investing Activities | $1.29M |
| Net Cash Flow From Investing Activities, Continuing | $1.29M |
| Net Cash Flow From Financing Activities | $11.90M |
| Net Cash Flow From Financing Activities, Continuing | $11.90M |
| Net Cash Flow | $0.00 |
| Net Cash Flow, Continuing | $0.00 |
| Comprehensive Income/Loss | -$31.04M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$31.04M |
| Other Comprehensive Income/Loss | $0.00 |